Cite

    Mattke, S. et al. (2020). Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times. Alzheimer's & dementia. 12 (1), p. n/a. [Online].